Showing results (581-590 of 885) with videos related to
Sort By:
Pageof 89
Cytokine|April 16, 2016
In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvantSimon D van Haren, Lakshmi Ganapathi, Ilana Bergelson, et al.JNCI Cancer Spectrum|October 3, 2023
Assessing characteristics of populations seen at Commission on Cancer facilities using Pennsylvania linked dataKristine G Reed, Zhaojun Sun, Jonathan G Yabes, et al.Infection and Immunity|July 16, 2002
Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasisRhea N Coler, Yasir A W Skeiky, Karen Bernards, et al.Science Translational Medicine|July 29, 2011
Targeting TLRs expands the antibody repertoire in response to a malaria vaccineSteven R Wiley, Vanitha S Raman, Anthony Desbien, et al.Journal of Dental Education|September 1, 2007
Use of the OSCE to evaluate brief communication skills training for dental studentsGabrielle F Cannick, Alice M Horowitz, David R Garr, et al.The Journal of Infectious Diseases|October 1, 1996
Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adultsD L Lakey, J J Treanor, R F Betts, et al.The Journal of Clinical Investigation|July 1, 1993
Interleukin 10 production correlates with pathology in human Leishmania donovani infectionsH W Ghalib, M R Piuvezam, Y A Skeiky, et al.Obesity Research|May 1, 1996
Nutrition and physical activity program to attenuate obesity and promote physical and metabolic fitness in elementary school childrenJ E Donnelly, D J Jacobsen, J E Whatley, et al.International Journal of Cancer|October 11, 2015
Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effectsPini Matzner, Liat Sorski, Lee Shaashua, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 19, 2013
Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasisA C Vallur, M S Duthie, C Reinhart, et al.Pageof 89